Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoluminal device induces insulin sensitivity and greater weight control than semaglutide in pigs.

Gut·2026
Same author

Correction: Post-Operative Safety Outcomes and 5-Year Healthcare Utilisation After Bariatric Surgery vs. Other Elective Types of Surgical Treatments - A Retrospective Observational Cohort Study.

Obesity surgery·2026
Same author

Post-Operative Safety Outcomes and 5-Year Healthcare Utilisation After Bariatric Surgery vs. Other Elective Types of Surgical Treatments - A Retrospective Observational Cohort Study.

Obesity surgery·2026
Same author

Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence.

Metabolism: clinical and experimental·2026
Same author

Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.

Diabetologia·2025
Same author

Cost-effectiveness analysis of surgical and non-surgical weight loss interventions in end-stage knee osteoarthritis and obesity: a Markov State model.

BMC public health·2025

Related Experiment Video

Updated: Jun 19, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion.

Donatella Gniuli1, Laura Leccesi, Caterina Guidone

  • 1Department of Internal Medicine and Diabetes Center, Catholic University, L.go Gemelli 8, 00168 Rome, Italy. dgniuli@gmail.com

Obesity Surgery
|November 4, 2009
PubMed
Summary

Bilio-pancreatic diversion surgery increases hypothyroidism risk in obese patients. Post-surgery, more patients developed subclinical or frank hypothyroidism, especially those with prior thyroid issues.

Related Experiment Videos

Last Updated: Jun 19, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Area of Science:

  • Endocrinology
  • Bariatric Surgery
  • Metabolic Disorders

Background:

  • Bilio-pancreatic diversion (BPD) is a bariatric surgery causing significant weight loss via malabsorption.
  • BPD alters entero-hepatic circulation, potentially impacting thyroid hormone metabolism.
  • The study investigates thyroid hormone changes following BPD in obese patients.

Purpose of the Study:

  • To evaluate modifications in circulating thyroid hormones after BPD.
  • To assess the prevalence of hypothyroidism before and after BPD.
  • To identify factors contributing to thyroid dysfunction post-BPD.

Main Methods:

  • Forty-five obese patients were studied pre- and 2-years post-BPD.
  • Assessed thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), and anti-thyroid antibodies.
  • Included lipid profile, glucose/insulin levels, HOMA IR index, and neck ultrasonography.

Main Results:

  • Pre-BPD, 23% had subclinical hypothyroidism; post-BPD, this rose to 40.42%.
  • 6.3% developed frank hypothyroidism post-BPD, without autoimmune thyroiditis.
  • Patients developing hypothyroidism post-BPD often had pre-existing thyroid alterations (goiter, cysts).

Conclusions:

  • BPD increases the prevalence of subclinical and frank hypothyroidism.
  • Mechanisms include iodine malabsorption and fT3 loss due to altered entero-hepatic circulation.
  • Iodine supplementation and careful thyroid hormone monitoring/therapy are recommended, especially for patients with pre-existing thyroid conditions.